Patents
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
02/2006
02/02/2006WO2006010590A1 N-acylated derivatives of dicarboxylic acids with amino acids and vegetable protein hydrolysates and their use in cosmetics and pharmaceuticals
02/02/2006WO2006010445A1 Trpv1 agonists, formulations containing them and uses thereof
02/02/2006WO2005123660A3 Polycationic compounds and uses thereof
02/02/2006US20060025594 Small molecule entry inhibitors
02/02/2006US20060025480 Benzoic acid derivatives as non nucleoside reverse transcriptase inhibitors
02/02/2006US20060025474 Bisphenyl compounds useful as vitamin D3 receptor agonists
02/02/2006US20060025396 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
02/02/2006CA2575341A1 Trpv1 agonists, formulations containing them and uses thereof
02/02/2006CA2573777A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
02/02/2006CA2570694A1 Amido compounds and their use as pharmaceuticals
02/01/2006EP1257525B1 Stabilizing agent for hydroxylamine solutions
02/01/2006CN1729160A Drugs for chronic pain
02/01/2006CN1729159A Amide compound and method of controlling plant disease with the same
02/01/2006CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
02/01/2006CN1239572C Polyalkoxylated superamides optionally functionalised, use as emulsifiers
02/01/2006CN1239495C Fungicides for control of take-all disease of plants
02/01/2006CN1239472C HIV integrase inhibitors
01/2006
01/31/2006US6992095 Stilbene compounds comprising an adamantyl group, compositions and methods thereof
01/26/2006WO2006010095A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
01/26/2006WO2006010094A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors
01/26/2006WO2005037205A3 Haloacetamide and azide substituted compounds and methods of use thereof
01/26/2006US20060020131 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents
01/26/2006US20060020003 Biphenyloxy-acids
01/26/2006CA2573138A1 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
01/26/2006CA2572775A1 Oxime derivative hydroxyethylamine aspartyl-protease inhibitors
01/26/2006CA2513080A1 Inhibitors of the anandamide transporter
01/25/2006EP1097158B1 Ligands for metals and metal-catalyzed processes
01/25/2006CN1726185A Formulations comprising selective androgen receptor modulators and using method thereof
01/24/2006US6989402 Thyroid receptor ligands and method II
01/24/2006CA2176706C Carbonyl containing compounds
01/19/2006WO2005062811A3 Catalytic sulfoxide-promoted c-h oxidation, and regioselective preparation of allylic carboxylates
01/19/2006US20060014963 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists
01/18/2006EP1615915A1 Phenacyl 2-hydroxy-3-diaminoalkanes
01/18/2006EP1615903A2 Synthesis of 2-hydroxy-n,n-dimethyl-3- [[ 2-[ 1(r)-(5-methyl-2-furanyl)propyl] amino] -3,4-dioxo-1-cyclobuten- 1-yl] amino benzamide
01/18/2006EP1219595B1 O-anisamide derivatives
01/18/2006CN1723207A Inhibitors of histone deacetylase
01/18/2006CN1723193A Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
01/17/2006US6987084 Photo-labile pro-fragrance conjugates
01/12/2006WO2006003923A1 Substituted benzene compound
01/12/2006WO2006002802A1 Phenyl derivatives comprising an acetylene group
01/12/2006WO2005102308A3 Crystalline and amorphous forms of efaproxiral sodium
01/12/2006US20060009651 Benzophenones as inhibitors of reverse transcriptase
01/12/2006US20060009529 Decyclization of a pyrrolo[1,2-a]pyrazino or pyrrolo[1,2-c]morpholino dione to a carboxylic acid, amidation with a substituted aniline, coupling and etherification with a phenol or amination with an aniline; hormone replacement therapies, bone and metabolic disorders, anticarcinogenic agents
01/12/2006US20060009484 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
01/10/2006US6984715 for production of polyurethane coatings; abrasion/solvent/weather resistance
01/10/2006US6984645 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes
01/05/2006WO2006002361A2 2-methylpropanamides and their use as pharmaceuticals
01/05/2006WO2006000324A2 New mao-b inhibitors
01/05/2006WO2006000288A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
01/05/2006US20060004108 N-[3,5-bis(trifluoromethyl)phenyl]-1,8,8-trimethyl-2,4-dioxobicyclo[3.2.1]octane-3-carboxamide; treating convulsions, epilepsy, episodic ataxia, myokymia, neonatal convulsions, cerebral ischemia, cerebral palsy, stroke, traumatic brain injury, traumatic spinal cord injury
01/05/2006US20060004097 Anti-retroviral moronic acid derivatives
01/05/2006US20060004091 Alpha-phenoxy- or phenylthio-alkanoic acid derivatives in which the phenyl ring is substituted with an acetylene group, e.g., 2-methyl-2-{2-methyl-4-[4-(4-trifluoromethyl-phenyl)-but-3-ynylsulfanyl]-phenoxy}-propionic acid; PPAR delta and/or PPAR alpha agonists used to treat diabetes
01/05/2006CA2584502A1 2-methylpropanamides and their use as pharmaceuticals
01/05/2006CA2572153A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
01/05/2006CA2571505A1 New mao-b inhibitors
01/05/2006CA2571309A1 Chemical compounds
01/04/2006EP1611091A1 Novel compounds
01/04/2006CN1717387A N-alkynyl-2- (substituted phenoxy) alkylamides and their use as fungicides
01/04/2006CN1717174A Fungicides
01/03/2006US6982348 for example, N[(1RS2SR)-2-(4-fluorophenyl)-2-hydroxy-1-[4-fluoromethyl)benzyl]ethyl]-6,7-dihydro-5H-benzo[a]cycloheptene-1-carboxamide; cholesteryl ester transfer protein inhibitory action; lipid-lowering agents
01/03/2006US6982346 Process of making D-panthenyl triacetate
01/03/2006US6982026 Mixing a feed stream that comprises at least one of an organic acid or an organic acid amide and at least one azeotroping agent; heating to produce heteroazeotrope vapor stream; separating the first vapor stream; producing first bottoms
01/03/2006CA2244695C Cyclic amic acid derivatives
12/2005
12/29/2005WO2005123668A1 Glucagon receptor antagonists, preparation and therapeutic uses
12/29/2005WO2005123660A2 Polycationic compounds and uses thereof
12/29/2005WO2005123646A2 Fluoroorganic compounds and anti-fouling treatments
12/29/2005US20050288367 Benzyloxy derivatives as MAOB inhibitors
12/29/2005US20050288338 Amido compounds and their use as pharmaceuticals
12/29/2005US20050288329 2-(4-Chlorophenyl)-N-[(1R,2R)-2-(benzyloxy)cyclohexyl]-2-methylpropanamide; modulators of 11- beta hydroxyl steroid dehydrogenase type 1 and/or mineralocorticoid receptor
12/29/2005US20050288282 Anticancer agents; antiproliferative agents
12/29/2005CA2570248A1 Polycationic compounds and uses thereof
12/29/2005CA2569459A1 Glucagon receptor antagonists, preparation and therapeutic uses
12/28/2005EP1608616A1 Biphenyl carboxylic amide p38 kinase inhibitors
12/28/2005EP1299352B1 Compounds to treat alzheimer's disease
12/28/2005CN1714073A Fungicides
12/28/2005CN1714070A Vitamin d receptor modulators
12/28/2005CN1713816A Fungicides
12/27/2005CA2362297C Ordered polyacetylenes and process for the preparation thereof
12/27/2005CA2305463C Aminobutanoic acid derivatives
12/22/2005WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005WO2005121081A1 Method for producing acetamidopyrrolidine derivative and intermediate compound thereof
12/22/2005WO2005121072A1 Hydroxyphenylhydroxy- alkylamides, reversible thermo- sensitive compositions and reversible thermal printing materials containing them, and color developing and reducing process with the same
12/22/2005WO2005121069A1 Levodopa prodrugs, and compositions and uses thereof
12/22/2005WO2005120477A2 N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators
12/22/2005WO2005090286B1 Opioid receptor antagonists
12/22/2005US20050283019 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005US20050282891 Parkinson's disease, depression, attention deficit disorder; schizophrenia, manic depression, cognitive impairment disorders, restless legs syndrome, periodic limb movement disorders, Huntington's disease, Tourette's syndrome, congestive heart failure, sustained release
12/22/2005US20050282872 Novel thyroid receptor ligands and method II
12/22/2005US20050282822 Therapeutic agents
12/22/2005CA2570179A1 Method for producing acetamidopyrrolidine derivative and intermediate compound thereof
12/22/2005CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005CA2568632A1 Levodopa prodrugs, and compositions and uses thereof
12/21/2005CN1711239A Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/15/2005WO2005062874A3 Compounds and compositions for delivering active agents
12/15/2005US20050277779 Antifungal and antimycobacterial basiliskamides
12/15/2005US20050277681 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
12/15/2005US20050277627 Colchinol derivatives as vascular damaging agents
12/15/2005DE102004025072A1 Verfahren zur Herstellung von Diphenyl-azetidinon-Derivaten Process for the preparation of diphenyl-azetidinone derivatives
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 157